Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases
- Authors
-
-
Fabio Franceschini Mitri
Department of Human Anatomy, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia/MG, Brazil
-
- Keywords:
- Nanotechnology, Nanomedicine, Nanodrugs, Bone Cancer, Osteosarcoma, Bone Infection, Osteoarthritis, Targeted Delivery.
- Abstract
-
The ever-evolving field of nanotechnology has been applied over the years as an amazing potential tool in bone disorders through the development of targeted drug nanosystems. Bone diseases can be referred as any bone condition able to cause morbidity or even mortality to the host. Osteosarcoma has been most investigated condition for management and treatment by nanomedicine, and several nanomaterials such as nanoparticles, nanocapsules, nanospheres, nanodiamonds are being used for drug delivery. Likewise, other bone diseases, such as osteoporosis, osteonecrosis, osteoarthritis, bone tuberculosis have received nanotherapy with a large rate of success. The nanomedicine seems to make up a targeting lack by conventional therapy and chemotherapy, besides appointing to a trend of conservative clinical treatment, especially for severe disorders. Additionally, nanomedicine has advanced over the years, therefore, there is a strong need to accelerate its application in bone diseases reducing the mortality rate related to these conditions. This review article provides an overview on the advances of nanotechnology over the last two decades and highlights the pathways of investigations for targeted delivery nanoensembles.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Lydia Hopp, Edith Willscher, Henry Löffler-Wirth, Hans Binder, Function Shapes Content: DNA-Methylation Marker Genes and their Impact for Molecular Mechanisms of Glioma , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Tchin Darré, Lantam Sonhaye, Mazamaesso Tchaou, Kokou Kanassoua, Abdoulatif Amadou, Aklesso Bagny, Alphonse Aman N’Guiessan, Koffi Amegbor, G. Napo-Koura, Histo-Epidemiological Profile of Digestive Cancers in Togo , Journal of Cancer Research Updates: Vol. 4 No. 3 (2015)
- Ghazala H. Rizwani, De-Shen Wang, Mansoor Ahmed, Amir Hassan, Zheng-Rong Lai, Affnan Zahid, Najia Mansoor, Huma Sharif, Zhe-Sheng Chen, Zhi Shi, Anticancer Activity of Five Traditionally Used Medicinal Plants' Extracts , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Jian-Yang Hu, Min-Feng Chen, Xue-Ping Lei, Zhen-Jian Zhuo, Hai-Yan Sun, Zhe-Sheng Chen, Zhi Shi, Dong-Mei Zhang, Wen-Cai Ye, Bufalin Induces Apoptosis of MDA-MB-231 Cell Through Activation of JNK/p53 Pathway , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Hossam M.M. Arafa, Raed S. Ismail, Nesreen Nabil, Adel M. Mostafa, Carnitine Deficiency: A Causative Clue or a Sequel in Carboplatin Myelosuppression , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Patrick A. Riley, Cancer: Evidence Consistent with Epigenetic Carcinogenesis , Journal of Cancer Research Updates: Vol. 11 (2022)
- Takuma Hayashi, Akiko Horiuchi, Kenji Sano, Gal Gur, Hiroyuki Aburatani, Osamu Ishiko, Nobuo Yaegashi, Tanri Shiozawa, Yae Kanai, Dorit Zharhary, Susumu Tonegawa, Ikuo Konishi, Biological Significance of the Proteasome Subunit LMP2/b1i as a Tumor Suppressor in Human Uterine Leiomyosarcoma , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Umesh C. Gupta, Subhas C. Gupta, A Guide for Future Therapeutics Based upon the Function of Enzymes and Proteins in Human Pathologic Metabolic Processes , Journal of Cancer Research Updates: Vol. 6 No. 3 (2017)
- Joseph V. Pergolizzi, Jr., Jo Ann LeQuang, Sigma Antagonists for Treatment of Neuropathic Pain Syndromes in Cancer Patients: A Narrative Review , Journal of Cancer Research Updates: Vol. 11 (2022)
- Joan A. Loayza-Castro, Luisa E.M. Vásquez-Romero, Lupita A.M. Valladolid-Sandoval, Enrique Vigil-Ventura, Nataly M. Sanchez-Tamay, Fiorella E. Zuzunaga-Montoya, Rafael Tapia-Limonchi, Víctor J. Vera-Ponce, Interleukin-6 as a Risk and Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis , Journal of Cancer Research Updates: Vol. 13 (2024)
You may also start an advanced similarity search for this article.